Permira acquires Atrium Innovations


hospital corridorPrivate equity firm Permira has bought natural health products company Atrium Innovations for C$24 per share.

Permira has agreed to buy all of the outstanding shares in the company and of all of its outstanding 5.75 per cent convertible unsecured subordinated debentures. In December Permira bought a 75 per cent stake in a deal that valued the business at C$1.1bn ($1bn).

Fonds de solidarité FTQ and Caisse de dépôt et placement du Québec agreed to roll-over their existing 12.5 per cent stakes in the business in the C$24 per share deal.

Atrium’s shares and debentures were delisted from the Toronto Stock Exchange last Friday.

The company owns healthcare practitioner and specialized retail product brands, which are distributed in more than 35 countries.

Copyright © 2014 AltAssets